Member Info for lukehere

"However this does now look like a decent trading position"
Swanny27 is correct with this assertion, for the best % increases in the TERN share price have consistently occurred around 4-8 weeks subsequent to a placing.
At the current 7.5p, I would regard any current purchase as a sound investment rather than a trading opportunity, although the two strategies naturally go hand in hand.
I am intending to invest further funds into TERN over that 4-8 week period whilst the share price in all likelihood remains becalmed.

Having viewed the CMD webinar again, I am not currently over eager to call out Al Sisto.
He does enjoy the full support of the TERN BoD and of the management of TERN's various investee companies.
Calling for an EGM has the potential to damage our well structured company along with the an unsettling of the already weak share price.
Some type of corporate action designed to provide sufficient funds to allay the omnipresent fear of a placing and to provide an ample financial runway for the next couple of years would most probably result in at the very least a doubling of the current SP.

Do not think in terms of "supporting the price" when opting, or otherwise, to invest in TERN at the current low level.
I bought a goodly amount last week including a few at sub 10p and viewed the purchases purely as being exceedingly good value.
The SP seems very likely to rise as the various strands of the investee's progress come more in to focus; no matter how inept the TERN BoD appear to we PIs.

Any upcoming strong rise in the TERN share price will quickly serve to snuff out the discontent currently in evidence.
As for EGM's, any move to secure such can be ignored by the BoD with consequential action requiring court intervention.
No thanks !

That is a moot point Nolupus.
If his earlier calls had been persistently successful, then fair enough.
As with all mere mortals though, such is not the case, I would not therefore attach too much weighting to his call on IMM for he has engaged in a long history of bias against the company.
If it turns out that nobbygnome is more astute than we optimists, then good on him.

Give me a good waft of hot air any day rather than a tackle shrivelling bucket of icy wigwam water.

Being prepared for Retirement more like.
The news has already stimulated the SP.
Imagine the uplift in sentiment should he exit all TERN related positions.
What Joy !!

There must be an acute shortage of green boxes looming for LSE, given the sheer weight of trolling in evidence on this thread.
I am anticipating that a decent RNS is in preparation, which should for once, have a positive and long lasting impact on the TERN share price.
BUY

Money to be made here.
No bid currently; yet this will change shortly.
I am buying.

Good link antelope except that you understate the magnitude of DA's achievement; for Device Authority is classed as one of just 10 "overall leaders" in addition to receiving an accolade for being a "top implementer".
This all augurs well for underpinning the approaching uplift in market sentiment.

Mrlofer
Q. Were the now Loan Note Holders insiders ? A. Yes
Q What was their motivation to provide BYOT with additional funds? A. A 9% coupon and a basement strike price.
It is a shame that we "clowns" could not obtain an invite to onboard this particular gravy train.

Dream on Gekkonls.
Positions have already been taken with a view to benefiting from any strengthening in the TERN SP.
In the event of renewed weakness then informed buying will once again re-emerge.

GMS borrowings in 2021 attracted an average LIBOR rate of 0.2%.
6 month LIBOR rate 12 months ago was just o.15%
6 month LIBOR rate today = 3.3% (or a twenty two fold increase) and is displaying a vigorous upward trend.
Should the ongoing dramatic increase in debt funding costs lead us to examine the similarly increasing risk profile.
I have sold my GMS stock.

Well said Still Waiting for highlighting that BobsSocks rivals Yuri Geller when delivering his biased and scripted googlies.

Do not encourage Uncle Lockjaw by regurgitating his further spurious claims.
His 51 society, I believe, relates to their target for the number of consecutive occasions that they can be proven totally incorrect when attempting to "forecast" a future event.

One no sooner corrals all the ne'er-do-wells into the filtered zone when hey presto another malcontent is created.
Teddy might strike, but only the once.
Time for a rendezvous with Tom and his drudges for you then.
Cheerio !

Intuition allied to a bit of common sense tells me that Avion will take out IMM in the short term.
Price ??
17p.

CauldStream7
Agreed.
There seems to be a paucity of information on "what happens next".
I understand that the content of their meeting is minuted , with Avion subsequently being provided with a copy.
As regards timing, we could maybe take the Minerva response time of 35 days as part guidance:-

"WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system (CNS) disorders, announced today that it has received the official meeting minutes from the Type C meeting with the U.S. Food and Drug Administration (FDA) held on March 2, 2022."

IMM are edging closer to a defining moment.
The FDA are due to respond to the meeting request in 14 days.
"If a meeting request is denied, notification to the sponsor or applicant will include an explanation
of the reason for the denial. Denials will be based on a substantive reason, not merely on the
absence of a minor element of the meeting request or meeting package items."
Hopefully though the request will accepted, in which case "the Type C meeting should be scheduled to occur within 75 days of FDA receipt of the written meeting request " or Sept 9th 2022.
Fingers crossed !

Green bin time for BobsSocks along with his line of condescending and patronising misinformation where he can harmonise admirably with his pals who are encouraged to sing a similar tune.
Cheerio